Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer

By MRCSEd S.R. WALSH, E. J. Cook, Mb Bch, F. Goulder, Mb Chb, T. Justin, D. Frcs, MS Frcs N.J. KEELING. Journal of Surgical Oncology, 2005

1,102 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/24a21c403eee4fb59dc2be73166bc7728d075611

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. C. Roxburgh
2. K. Charles
3. S. Clarke

Citations in the corpus

• Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. (2010, methodology): “Walsh and coworkers examined the prognostic value of another inflammation-based score, the NLR, in primary operable colorectal cancer patients [26].”
• The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. (2013, background): “[8,18–49]).”
• Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population (2012, background): “Many cancer survival studies have suggested that NLR is a significant predictor of overall and disease specific survival of patients [19,20].”